Pharmacoeconomic Modeling of Biosimilars in the US: A Conceptual Framework

Society of Medical Decision Making 37th Annual North American Meeting

Incremental healthcare resource utilization and costs in US patients with Cushing’s disease compared with diabetes mellitus and population controls

Cushing's Disease, Diabetes, Endocrinology, Insurance Claims, Secondary Data Analysis

Cost–effectiveness of treatments for high-risk myelodysplastic syndromes after failure of firstline hypomethylating agent therapy

Expert Review of Pharmacoeconomics & Outcomes Research
Cancer, Cost Effectiveness Analysis, Economic Models, Hematology, Myelodysplastic Syndrome, Oncology

Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States

American Journal of Clinical Oncology
Cancer, Colorectal Cancer, Cost Effectiveness Analysis, Economic Models, Oncology